Skip to content

Clinical trials

Essential Hypertension trials in Germany with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Essential Hypertension Phase: Not applicable Country / region: Germany Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20161
20181
20191
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting2
Completed2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ReCor Medical, Inc.2
Alma Phil Gmbh1
Charite University, Berlin, Germany1
Cibiem, Inc.1
Orchestra BioMed, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Essential Hypertension6
Hypertension4
Vascular Diseases2
Cardiovascular Diseases1
Dizziness1
Heart Failure1
Isolated Systolic Hypertension1
Metabolic Syndrome1
Obesity1
Overweight1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.